Related Experiment Videos
[Amyotrophic lateral sclerosis in a patient with Waldenstrom's macroglobulinemia]
P Vannucci1, M Castiglioni, M Filidei
1Unità Operativa II, Medicina Interna, USL n. 5 Valdera, Pontedera, Pisa.
Abstract:
Although a peripheral neuropathy is the best known neurological complication of Waldenstrom's Macroglobulinemia (WM), the association of Amyotrophic Lateral Sclerosis (ALS), or other Motor Neuron Diseases (MND) with monoclonal gammopathies is described. We report the case of a male patient (41 years old) with WM and ALS. Whether monoclonal gammopathies play a role in the pathogenesis of MND is unclear but is la possible that patients might have antibodies against motor neurons. In our reported case neurologic symptoms were the first and the most important manifestations of the underlying hemopathy and despite plasmapheresis and immunosuppressive treatment ALS syndrome progressed. The neurologic disease worsened despite the improvement of WM.
Insights
Waldenstrom's Macroglobulinemia (WM) can be associated with Amyotrophic Lateral Sclerosis (ALS), a rare motor neuron disease. This case highlights neurological symptoms as primary manifestations, progressing despite treatment for the underlying hemopathy.
Area of Science:
- Neurology
- Hematology
- Oncology
Background:
- Waldenstrom's Macroglobulinemia (WM) is a rare lymphoproliferative disorder.
- Peripheral neuropathy is a known neurological complication of WM.
- The association between monoclonal gammopathies and Motor Neuron Diseases (MND), including Amyotrophic Lateral Sclerosis (ALS), is less understood.
Observation:
- A case report of a 41-year-old male patient diagnosed with both WM and ALS.
- Neurological symptoms, specifically ALS, were the initial and most prominent manifestations.
- The patient's ALS syndrome progressed despite therapeutic interventions.
Findings:
- The study presents a rare co-occurrence of WM and ALS in a patient.
- Monoclonal gammopathies are being investigated for their potential role in MND pathogenesis.
- Possible autoimmune mechanisms, such as antibodies targeting motor neurons, are hypothesized.
Implications:
- This case underscores the importance of considering underlying hematological disorders in patients presenting with neurological conditions like ALS.
- Further research is needed to elucidate the pathogenic link between monoclonal gammopathies and MND.
- Understanding this association may lead to novel diagnostic and therapeutic strategies for patients with both conditions.